Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

Integrating CRISPR Technology with Key Genetic Markers in Pancreatic Cancer: A New Frontier in Targeted Therapies
Dimitrios Stefanoudakis
SynBio (2025) Vol. 3, Iss. 1, pp. 1-1
Open Access | Times Cited: 1
Pre-clinical Models of Metastasis in Pancreatic Cancer
Maria Angels de Miquel, Shuman Zhang, Christian Pilarsky
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 33
ABI2‐mediated MEOX2/KLF4‐NANOG axis promotes liver cancer stem cell and drives tumour recurrence
Jiandi Chen, Huizi Li, Bin Zhang, et al.
Liver International (2022) Vol. 42, Iss. 11, pp. 2562-2576
Open Access | Times Cited: 22
Dampening HOTAIR sensitizes the gastric cancer cells to oxaliplatin through miR‐195‐5p and ABCG2 pathway
Yaomin Luo, Xintong Lu, Wenrong Ma, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 22, pp. 3591-3600
Open Access | Times Cited: 13
KRAS Inhibition Reverses Chemotherapy Resistance Promoted by Therapy-Induced Senescence-like in Pancreatic Ductal Adenocarcinoma
Analía Meilerman Abuelafia, Patricia Santofimia‐Castaño, Matías Estarás, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma
Analía Meilerman Abuelafia, Patricia Santofimia‐Castaño, Matías Estarás, et al.
Translational Oncology (2025) Vol. 57, pp. 102421-102421
Closed Access
Unravelling the complexities of resistance mechanism in pancreatic cancer: insights from in vitro and ex-vivo model systems
Giulia Lencioni, Alessandro Gregori, Belen Toledo B, et al.
Seminars in Cancer Biology (2024)
Open Access | Times Cited: 3
Epigenetic control of pancreatic cancer metastasis
Lukas Krauß, Carolin Schneider, Elisabeth Heßmann, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 4, pp. 1113-1131
Open Access | Times Cited: 7
Discovery platforms for RNA therapeutics
Giulio Ciucci, Luca Braga, Serena Zacchigna
British Journal of Pharmacology (2024)
Open Access | Times Cited: 2
Innovating cancer drug discovery with refined phenotypic screens
Zhenyi Wang, Alžbeta Hulı́ková, Pawel Swietach
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 8, pp. 723-738
Open Access | Times Cited: 2
Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy
Ozen Leylek, Megan E. Honeywell, Michael J. Lee, et al.
Gastric Cancer (2024) Vol. 27, Iss. 6, pp. 1201-1219
Open Access | Times Cited: 2
Exploring Epigenetic Dynamics Unveils a Super-Enhancer-Mediated NDRG1-β-Catenin Axis in Modulating Gemcitabine Resistance in Pancreatic Cancer
Dianhui Wei, Lili Yuan, Xiaoli Xu, et al.
Cancer Letters (2024), pp. 217284-217284
Closed Access | Times Cited: 2
Co-essentiality analysis identifies PRR12 as a cohesin interacting protein and contributor to genomic integrity
Alexandra L. Nguyen, Eric M. Smith, Iain M. Cheeseman
Developmental Cell (2024)
Closed Access | Times Cited: 2
Genome-wide CRISPR/Cas9 screening for drug resistance in tumors
Zhongyan Zhang, Hailiang Wang, Qian Yan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Genomic analysis reveals HDAC1 regulates clinically relevant transcriptional programs in Pancreatic cancer
Carter Wright, Emily R. Gordon, Sara J. Cooper
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
DNA methylation‐associated allelic inactivation regulates Keratin 19 gene expression during pancreatic development and carcinogenesis
Jana Krüger, Anja Fischer, Markus Breunig, et al.
The Journal of Pathology (2023) Vol. 261, Iss. 2, pp. 139-155
Open Access | Times Cited: 4
Cancer Stem Cells: Current Challenges and Future Perspectives
Muhammad Vaseem Shaikh, Stefan Custers, Alisha Anand, et al.
Methods in molecular biology (2024), pp. 1-18
Closed Access | Times Cited: 1
Co-Essentiality Analysis Identifies PRR12 as a Regulator of Cohesin and Genome Integrity
Alexandra L. Nguyen, Eric N. Smith, Iain M. Cheeseman
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Multi-Omics Analysis of NCI-60 Cell Line Data Reveals Novel Metabolic Processes Linked with Resistance to Alkylating Anti-Cancer Agents
Blake R. Rushing
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13242-13242
Open Access | Times Cited: 3
Forward Genetic Screens as Tools to Investigate Role and Mechanisms of EMT in Cancer
Ákos Gasparics, Attila Sebe
Cancers (2022) Vol. 14, Iss. 23, pp. 5928-5928
Open Access | Times Cited: 5
M6A and lactylation modification-related signature predicts prognosis and immunotherapy response in hepatocellular carcinoma
Ren Hui-li, Jianhua Liu, Shaohui Zhang
(2024)
Closed Access
Applications of CRISPR technology
Zhiyan Du
Elsevier eBooks (2024), pp. 23-74
Closed Access
A small Rho GTPase RAB25 with a potential role in chemotherapy resistance in pancreatic cancer
Amira Kohil, Sayeda S. Amir, Axel Behrens, et al.
Cancer Biomarkers (2022) Vol. 36, Iss. 2, pp. 133-145
Closed Access | Times Cited: 2
Genetic Functional Similarity Clustering Using CRISPR-Cas9 Knockout Data
Jion Lee, Minhyung Cho, Han sol Hong, et al.
Research Square (Research Square) (2023)
Open Access
Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy
Ozen Leylek, Megan E. Honeywell, Michael J. Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top